Drug intelligence / Profile preview

PD-L1-Fc

Development stage
Preclinical
Lead developer
WEHI
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01

Overview

PD-L1-Fc is a recombinant fusion protein consisting of the extracellular domain of human programmed death-ligand 1 (PD-L1) fused to the Fc region of human immunoglobulin G (IgG). It is designed to mimic the natural ligand for programmed death-1 (PD-1), an inhibitory receptor expressed on T cells. By engaging with PD-1, PD-L1-Fc delivers inhibitory signals that suppress T-cell activation and proliferation. This mechanism has been used in research settings to study immune checkpoint pathways and T cell regulation. Notably, studies have shown that plate-bound or coimmobilized PD-L1-Fc can inhibit T-cell proliferation even independently of direct interaction with CD80 or other binding partners, suggesting a nonspecific mechanism when used in certain assay formats[5]. The primary use of this molecule is as a research tool rather than as a therapeutic agent.

Other names
Programmed death-ligand 1 Fc fusion proteinPD-L1 Ig fusion proteinPD-L-1 Ig fusion proteinPD-L 1 Ig fusion protein
02

Targets

PDCD1 (Programmed cell death protein 1 receptor)

Beyond the preview

Go deeper on PD-L1-Fc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PD-L1-Fc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call